Esophageal lichen planus: towards diagnosis of an underdiagnosed disease
Authors:
- Franziska SchauerFSFranziska Schauer
- Carmen MonasterioCMCarmen Monasterio
- Kristin Technau-HafsiKTKristin Technau-Hafsi
- Johannes Steffen KernJKJohannes Steffen Kern
- Adhara LazaroALAdhara Lazaro
- Peter DeibertPDPeter Deibert
- Peter HasselblattPHPeter Hasselblatt
- Henning SchwachaHSHenning Schwacha
- Steffen HeegSHSteffen Heeg
- Volker BrassVBVolker Brass
- Armin KüllmerAKArmin Küllmer
- Arthur Robert SchmidtASArthur Robert Schmidt
- 3 October 2019
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 54 (10) , 1189-1198
Abstract
Background: Although lichen planus (LP) is a common skin disorder, the prevalence of esophageal involvement (ELP) and its clinical manifestations are poorly defined. We aimed to establish diagnostic criteria and characterize disease outcomes of ELP. Methods: Clinical, endoscopic, histological, and immunofluorescence data from consecutive patients with known LP between 2013 and 2018 were analyzed. We established endoscopic (denudation and tearing of the mucosa, hyperkeratosis and trachealization) and histological criteria (mucosal detachment, T-lymphocytic infiltrate, intraepithelial apoptosis, dyskeratosis, and fibrinogen deposits along the basement membrane) to grade disease severity. Endoscopic findings were correlated with clinical symptoms. Response to medical therapy was monitored. Results: Fifty-two consecutive patients (median age 59.5 years) were analyzed. According to our grading system, 16 patients were considered as severe and 18 as mild ELP. Dysphagia was the only symptom which differentiated patients with severe (14/16) or mild ELP (8/18) from patients without ELP (1/18). Concomitant oral and genital involvement of LP was associated with the presence of ELP, while oral involvement alone was not. Follow-up of 14/16 patients with severe EPL for at least one year revealed that most of these patients responded to topical corticosteroids (budesonide: n = 9/10 or fluticasone n = 2/2). Three budesonide patients experienced a resolution of symptomatic esophageal stenosis. Conclusions: Esophageal involvement of LP is frequent, but may be asymptomatic. ELP can be diagnosed using the diagnostic criteria proposed here. Dysphagia and combined oral and genital manifestation are associated with ELP. Therapy with topical corticosteroids appears to be a prudent therapeutic approach for ELP.Keywords
This publication has 52 references indexed in Scilit:
- Oral, Esophageal and Cutaneous Lichen Ruber Planus Controlled with Alitretinoin: Case Report and Review of the LiteratureDermatology, 2013
- Erfolgreiche Therapie einer Lichen-planus-Ösophagitis mit topischem BudesonidZeitschrift für Gastroenterologie, 2012
- Lymphocytic oesophagitis: clinicopathological aspects of an emerging conditionGut, 2011
- Lichen planus of the esophagus: What dermatologists need to knowJournal of the American Academy of Dermatology, 2011
- Upper gastrointestinal findings and detection of Helicobacter pylori in patients with oral lichen planusClinical and Experimental Dermatology, 2010
- Esophagitis dissecans superficialis and autoimmune bullous dermatoses: A reviewWorld Journal of Gastrointestinal Endoscopy, 2010
- Esophagitis Dissecans Superficialis (“Sloughing esophagitis”)American Journal of Surgical Pathology, 2009
- High prevalence of esophageal involvement in lichen planus: a study using magnification chromoendoscopyEndoscopy, 2009
- Esophageal lichen planus: a series of eight cases including a patient with esophageal verrucous carcinoma. A case seriesEndoscopy, 2008
- Lichen planus with Oesophageal InvolvementDigestion, 2002